Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Will Gilead Sciences Blow It Next Quarter?
Motley Fool
Wednesday, September 28, 2011 - 12:32pm
tags:
Gilead
Rexahn Pharmaceuticals advances pancreatic cancer drug
Bizjournals.com
Wednesday, September 28, 2011 - 12:31pm
tags:
Rexahn, pancreatic cancer
Whether Neptune Can Overcome Market Weigh-Down And Deliver On Milestones
Seeking Alpha
Wednesday, September 28, 2011 - 11:45am
tags:
Neptune, China
3 Oversold Biotech Stocks Undervalued By Levered Free Cash Flow
Seeking Alpha
Wednesday, September 28, 2011 - 11:37am
tags:
Momenta, China Biologic, Acadia
Teva exec says Cephalon deal still on track
Philadelphia Inquirer, PA
Wednesday, September 28, 2011 - 11:35am
tags:
Teva Pharmaceuticals, Cephalon, M&A
Nordisk Seeks Approval For Degludec Insulin In Europe And US
NASDAQ.com
Wednesday, September 28, 2011 - 11:33am
tags:
Novo Nordisk, degludec, diabetes, insulin, Europe, FDA
J&J company Ethicon Endo-Surgery buys medical device firm SterilMed for undisclosed terms
Yahoo/AP
Wednesday, September 28, 2011 - 11:32am
tags:
JNJ, Ethicon-Endo Surgery, M&A, SterilMed
Amgen and the Supremes: Did the CEO Know About a Kickback Scheme?
BNET Pharma
Wednesday, September 28, 2011 - 9:21am
tags:
Supreme Court, Amgen, Epogen, Kevin Sharer, kickbacks, Aranesp
Astellas halts development of anti-clotting drug
Reuters
Wednesday, September 28, 2011 - 9:19am
tags:
Astellas, YM150, anti-clotting
The Wisdom Of The Crowds And Sangamo's Phase II B Clinical Trial Results
Seeking Alpha
Wednesday, September 28, 2011 - 9:17am
tags:
Sangamo BioSciences, SB-509, diabetic neuropathy
Novartis' Respiratory Ambitions Are On Track
Seeking Alpha
Wednesday, September 28, 2011 - 9:16am
tags:
Novartis, NVA237, COPD
[video]Tranzyme CEO: We Were Lucky to Go Public
TheStreet.com
Wednesday, September 28, 2011 - 9:15am
tags:
Tranzyme, Pharma CEOs, Vipin Gurg, IPOs
Novartis Drug Afinitor May Be A Blockbuster Breast Cancer Treatment
Seeking Alpha
Tuesday, September 27, 2011 - 7:33pm
tags:
breast cancer, Novartis, Afinitor
Merck, Sanofi’s Gardasil Beats Glaxo’s Rival Vaccine on Cost
Bloomberg
Tuesday, September 27, 2011 - 7:32pm
tags:
HPV, Gardasil, vaccines, Sanofi, GSK, Cervarix
Bristol-Myers Squibb Zeroes In On A Blockbuster Cancer Drug
Seeking Alpha
Tuesday, September 27, 2011 - 7:31pm
tags:
Bristol-Myers Squibb, Orencia, MDX-1106, BMS-936558, Ono Pharmaceutical
J&J's Doxil Woes Show Shortages Aren't Easily Fixed
Motley Fool
Tuesday, September 27, 2011 - 7:26pm
tags:
Doxil, JNJ, drug shortages, cancer
No consolation for Sanofi as Genzyme scrambles
Fierce Pharma
Tuesday, September 27, 2011 - 12:02pm
tags:
Genzyme, Sanofi
Tianyin Pharmaceuticals' Management Discusses Q4 2011 Results - Earnings Call Transcript
Seeking Alpha
Tuesday, September 27, 2011 - 12:00pm
tags:
earnings, Tianyin Pharmaceutical
Will the FDA Yank Bayer’s Risky Birth-Control Pill Yaz?
BNET Pharma
Tuesday, September 27, 2011 - 11:59am
tags:
Bayer, birth control pill, FDA, Yaz, Yasmin
Pens Vs. Payments In Pharmaceutical Marketing
Forbes
Tuesday, September 27, 2011 - 11:53am
tags:
physician payments

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.